Stock BCT BRIACELL THERAPEUTICS CORP.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. BriaCell Therapeutics Corp.

Equities

BCT

CA1079301091

Market Closed - Toronto S.E.
Other stock markets
 03:25:15 2024-04-29 pm EDT 		5-day change 1st Jan Change
2.95 CAD +0.68% Intraday chart for BriaCell Therapeutics Corp. +0.34% -62.18%
Apr. 24 BriaCell Therapeutics to Present Bria-IMT Phase 2 Findings at American Society of Clinical Oncology Annual Meeting MT
Apr. 10 BriaCell 2024 AACR Preclinical Poster Confirms Strong Anti-Cancer Activity of Bria-OTS+? and Bria-PROS+? Clinical Candidates for Breast and Prostate Cancer CI

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
BriaCell Has Reports 71% Central Nervous System Response Rate in Advanced Breast Cancer Patients
MT
BriaCell Brief: Has Reported 71% Central Nervous System Response Rate in Advanced Breast Cancer Patients; Comes After Shares Jumped 18% on Wednesday
MT
BriaCell Therapeutics Corp. Reports 71% Central Nervous System Response Rate in Advanced Breast Cancer Patients
CI
HC Wainwright Adjusts BriaCell Therapeutics' Price Target to $20 From $24.85, Keeps Buy Rating
MT
HC Wainwright Initiates BriaCell Therapeutics at Buy With $25 Price Target
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. BCT Stock
  4. News BriaCell Therapeutics Corp.
  5. Analyst Reco.